Compare VIRT & INDV Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | VIRT | INDV |
|---|---|---|
| Founded | 2008 | N/A |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Investment Bankers/Brokers/Service | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 5.1B | 4.7B |
| IPO Year | 2014 | 2014 |
| Metric | VIRT | INDV |
|---|---|---|
| Price | $57.71 | $37.96 |
| Analyst Decision | Hold | |
| Analyst Count | 5 | 0 |
| Target Price | ★ $45.60 | N/A |
| AVG Volume (30 Days) | 1.1M | ★ 1.4M |
| Earning Date | 04-29-2026 | 06-08-2026 |
| Dividend Yield | ★ 1.89% | N/A |
| EPS Growth | 72.73 | ★ 8100.00 |
| EPS | ★ 3.62 | 0.69 |
| Revenue | ★ $3,632,118,000.00 | $1,239,000,000.00 |
| Revenue This Year | N/A | N/A |
| Revenue Next Year | $1.34 | N/A |
| P/E Ratio | ★ $29.51 | $57.99 |
| Revenue Growth | ★ 26.25 | 4.29 |
| 52 Week Low | $31.55 | $21.16 |
| 52 Week High | $68.02 | $42.81 |
| Indicator | VIRT | INDV |
|---|---|---|
| Relative Strength Index (RSI) | 46.27 | 40.74 |
| Support Level | $56.14 | $38.47 |
| Resistance Level | $60.97 | $41.88 |
| Average True Range (ATR) | 2.22 | 1.54 |
| MACD | -0.34 | -0.24 |
| Stochastic Oscillator | 56.84 | 23.98 |
Virtu Financial Inc is a financial firm that leverages technology to deliver liquidity to the world-wide markets and transparent trading solutions to its clients. The company's operating segment includes Market Making; and Execution Services. The non-operating segment of the company includes the Corporate segment. The company generates maximum revenue from the market-making segment. The Market Making segment principally consists of market-making in the cash, futures, and options markets across equities, options, fixed income, currencies, and commodities. Geographically, it derives a majority of its revenue from the United States and also has a presence in Ireland and Other Countries.
Indivior Pharmaceuticals Inc is a specialty pharmaceutical company singularly focused on delivering evidence-based treatment and advancing understanding of opioid use disorder (OUD) as a chronic but treatable brain disease. The company derives revenues from customers through the development, manufacture and sale of buprenorphine-based prescription drugs for treatment of opioid dependence and related disorders. The company's products include: Sublocade (buprenorphine extended-release monthly injection), and Suboxone (buprenorphine and naloxone sublingual film).